How should I switch a patient from atenolol 50 mg to propranolol extended‑release 60 mg?

Switching from Atenolol 50mg to Propranolol Extended-Release 60mg

You can directly switch from atenolol 50mg to propranolol extended-release 60mg without a washout period, but the propranolol ER 60mg dose is likely underdosing compared to the atenolol 50mg—consider starting at propranolol ER 80-120mg instead for equivalent beta-blockade.

Dose Equivalency Considerations

The proposed switch presents a dosing mismatch. Based on comparative antihypertensive studies, atenolol 50mg daily provides similar or greater blood pressure reduction than propranolol 80-160mg daily 1. In one direct comparison, atenolol 50mg demonstrated equivalent efficacy to propranolol 160mg for blood pressure control 1. This suggests propranolol ER 60mg significantly underdoses relative to atenolol 50mg.

For cardiovascular indications (hypertension, angina, arrhythmias), propranolol ER 80-160mg daily represents a more appropriate equivalent dose 2, 3, 4. The FDA-approved dosing for propranolol ER starts at 80mg daily for hypertension, with usual maintenance doses of 120-160mg daily 4.

Switching Methodology

Direct substitution without tapering or washout is safe for beta-blocker switches in stable patients 5, 6, 7. Both atenolol and propranolol are beta-blockers, so there's no risk of withdrawal syndrome or dangerous drug interactions when switching directly.

Practical Switching Protocol:

• Stop atenolol 50mg in the morning
• Start propranolol ER 80-120mg the same day (not 60mg)
• Monitor heart rate and blood pressure within 3-7 days
• Titrate propranolol ER up to 120-160mg daily if needed for adequate control 4

The extended-release formulation reaches peak levels at approximately 6 hours and provides 24-hour coverage 4, 8.

Key Pharmacologic Differences

Atenolol is cardioselective (β1-selective) while propranolol is non-selective (β1 and β2 blockade) 9, 2, 3. This matters clinically:

• Propranolol carries higher risk in patients with asthma, COPD, or reactive airway disease due to β2 blockade causing bronchoconstriction 9
• Atenolol is preferred in patients with bronchospastic disease requiring a beta-blocker 2, 3
• Propranolol is lipophilic and crosses the blood-brain barrier, potentially causing CNS effects (sleep disturbances, nightmares, fatigue) that atenolol (hydrophilic) does not 4, 10
• Atenolol is renally eliminated (adjust for CrCl <35 mL/min), while propranolol undergoes hepatic metabolism 2, 3, 4

Common Pitfalls to Avoid

1. Don't assume mg-for-mg equivalence: Propranolol requires 1.5-3x higher doses than atenolol for similar effects 1

2. Don't use propranolol ER 60mg as maintenance: This dose is below the FDA-recommended starting dose of 80mg for hypertension 4 and will likely provide inadequate beta-blockade

3. Screen for contraindications before switching: Propranolol's non-selective blockade makes it inappropriate for patients with asthma, severe COPD, or decompensated heart failure 9, 2, 3

4. Monitor for new CNS side effects: Sleep disturbances occur more frequently with propranolol than atenolol due to CNS penetration 10. If this develops, consider switching back to atenolol or using an alternative cardioselective agent

5. Adjust for renal vs hepatic dysfunction: If the patient has renal impairment requiring atenolol dose reduction, propranolol may actually be advantageous (hepatic metabolism). Conversely, severe liver disease favors atenolol 2, 3

Monitoring After Switch

• Check heart rate and blood pressure within 3-7 days to assess adequacy of beta-blockade
• Target heart rate typically 60-70 bpm at rest for most indications 11
• Assess for new symptoms: sleep disturbances, fatigue, bronchospasm, or worsening heart failure
• Titrate dose upward if control inadequate: propranolol ER can be increased to 120-160mg daily (usual maintenance) or up to 320mg daily for angina 4